Feprazone

DB13364

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 320.392
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

149 Data
Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Feprazone.
Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Feprazone.
Bromfenac The risk or severity of adverse effects can be increased when Bromfenac is combined with Feprazone.
Nepafenac The risk or severity of adverse effects can be increased when Nepafenac is combined with Feprazone.
Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Feprazone.
Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Feprazone.
Tenoxicam The risk or severity of adverse effects can be increased when Tenoxicam is combined with Feprazone.
Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Feprazone.
Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Feprazone.
Rofecoxib The risk or severity of adverse effects can be increased when Rofecoxib is combined with Feprazone.
Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Feprazone.
Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Feprazone.
Valdecoxib The risk or severity of adverse effects can be increased when Valdecoxib is combined with Feprazone.
Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Feprazone.
Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Feprazone.
Mefenamic acid The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Feprazone.
Naproxen The risk or severity of adverse effects can be increased when Naproxen is combined with Feprazone.
Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Feprazone.
Phenylbutazone The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Feprazone.
Meloxicam The risk or severity of adverse effects can be increased when Meloxicam is combined with Feprazone.
Carprofen The risk or severity of adverse effects can be increased when Carprofen is combined with Feprazone.
Diflunisal The risk or severity of adverse effects can be increased when Diflunisal is combined with Feprazone.
Suprofen The risk or severity of adverse effects can be increased when Suprofen is combined with Feprazone.
Salicylic acid The risk or severity of adverse effects can be increased when Salicylic acid is combined with Feprazone.
Meclofenamic acid The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Feprazone.
Oxaprozin The risk or severity of adverse effects can be increased when Oxaprozin is combined with Feprazone.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Feprazone.
Balsalazide The risk or severity of adverse effects can be increased when Balsalazide is combined with Feprazone.
Ibuprofen The risk or severity of adverse effects can be increased when Ibuprofen is combined with Feprazone.
Olsalazine The risk or severity of nephrotoxicity can be increased when Feprazone is combined with Olsalazine.
Lumiracoxib The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Feprazone.
Magnesium salicylate The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Feprazone.
Salsalate The risk or severity of adverse effects can be increased when Salsalate is combined with Feprazone.
Choline magnesium trisalicylate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Feprazone.
Antipyrine The risk or severity of adverse effects can be increased when Antipyrine is combined with Feprazone.
Tiaprofenic acid The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Feprazone.
Etoricoxib The risk or severity of adverse effects can be increased when Etoricoxib is combined with Feprazone.
Oxyphenbutazone The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Feprazone.
Niflumic acid The risk or severity of adverse effects can be increased when Niflumic acid is combined with Feprazone.
Benoxaprofen The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Feprazone.
Zomepirac The risk or severity of adverse effects can be increased when Zomepirac is combined with Feprazone.
Lornoxicam The risk or severity of adverse effects can be increased when Lornoxicam is combined with Feprazone.
Aceclofenac The risk or severity of adverse effects can be increased when Aceclofenac is combined with Feprazone.
Zaltoprofen The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Feprazone.
Azapropazone The risk or severity of adverse effects can be increased when Azapropazone is combined with Feprazone.
Felbinac The risk or severity of adverse effects can be increased when Felbinac is combined with Feprazone.
Parecoxib The risk or severity of adverse effects can be increased when Parecoxib is combined with Feprazone.
Salicylamide The risk or severity of adverse effects can be increased when Salicylamide is combined with Feprazone.
Kebuzone The risk or severity of adverse effects can be increased when Kebuzone is combined with Feprazone.
Isoxicam The risk or severity of adverse effects can be increased when Isoxicam is combined with Feprazone.
Indoprofen The risk or severity of adverse effects can be increased when Indoprofen is combined with Feprazone.
Ibuproxam The risk or severity of adverse effects can be increased when Ibuproxam is combined with Feprazone.
Floctafenine The risk or severity of adverse effects can be increased when Floctafenine is combined with Feprazone.
Fenbufen The risk or severity of adverse effects can be increased when Fenbufen is combined with Feprazone.
Etofenamate The risk or severity of adverse effects can be increased when Etofenamate is combined with Feprazone.
Epirizole The risk or severity of adverse effects can be increased when Epirizole is combined with Feprazone.
Loxoprofen The risk or severity of adverse effects can be increased when Loxoprofen is combined with Feprazone.
Droxicam The risk or severity of adverse effects can be increased when Droxicam is combined with Feprazone.
Tolfenamic acid The risk or severity of adverse effects can be increased when Tolfenamic acid is combined with Feprazone.
Clonixin The risk or severity of adverse effects can be increased when Clonixin is combined with Feprazone.
Tepoxalin The risk or severity of adverse effects can be increased when Tepoxalin is combined with Feprazone.
Flunixin The risk or severity of adverse effects can be increased when Flunixin is combined with Feprazone.
Tinoridine The risk or severity of adverse effects can be increased when Tinoridine is combined with Feprazone.
Alclofenac The risk or severity of adverse effects can be increased when Alclofenac is combined with Feprazone.
Fentiazac The risk or severity of adverse effects can be increased when Fentiazac is combined with Feprazone.
Suxibuzone The risk or severity of adverse effects can be increased when Suxibuzone is combined with Feprazone.
Bumadizone The risk or severity of adverse effects can be increased when Bumadizone is combined with Feprazone.
Alminoprofen The risk or severity of adverse effects can be increased when Alminoprofen is combined with Feprazone.
Bufexamac The risk or severity of adverse effects can be increased when Bufexamac is combined with Feprazone.
Difenpiramide The risk or severity of adverse effects can be increased when Feprazone is combined with Difenpiramide.
Nifenazone The risk or severity of adverse effects can be increased when Feprazone is combined with Nifenazone.
Lonazolac The risk or severity of adverse effects can be increased when Feprazone is combined with Lonazolac.
Tenidap The risk or severity of adverse effects can be increased when Feprazone is combined with Tenidap.
Bendazac The risk or severity of adverse effects can be increased when Feprazone is combined with Bendazac.
Pranoprofen The risk or severity of adverse effects can be increased when Feprazone is combined with Pranoprofen.
Propyphenazone The risk or severity of adverse effects can be increased when Feprazone is combined with Propyphenazone.
Proglumetacin The risk or severity of adverse effects can be increased when Feprazone is combined with Proglumetacin.
Guacetisal The risk or severity of adverse effects can be increased when Feprazone is combined with Guacetisal.
Ethenzamide The risk or severity of adverse effects can be increased when Feprazone is combined with Ethenzamide.
Carbaspirin calcium The risk or severity of adverse effects can be increased when Feprazone is combined with Carbaspirin calcium.
Mofebutazone The risk or severity of adverse effects can be increased when Feprazone is combined with Mofebutazone.
Proquazone The risk or severity of adverse effects can be increased when Feprazone is combined with Proquazone.
Benorilate The risk or severity of adverse effects can be increased when Feprazone is combined with Benorilate.
Pirprofen The risk or severity of adverse effects can be increased when Feprazone is combined with Pirprofen.
Acemetacin The risk or severity of adverse effects can be increased when Feprazone is combined with Acemetacin.
Imidazole salicylate The risk or severity of adverse effects can be increased when Feprazone is combined with Imidazole salicylate.
Benzydamine The risk or severity of adverse effects can be increased when Benzydamine is combined with Feprazone.
Icosapent The risk or severity of adverse effects can be increased when Icosapent is combined with Feprazone.
Antrafenine The risk or severity of adverse effects can be increased when Antrafenine is combined with Feprazone.
Dexibuprofen The risk or severity of adverse effects can be increased when Dexibuprofen is combined with Feprazone.
Trolamine salicylate The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Feprazone.
Cimicoxib The risk or severity of adverse effects can be increased when Cimicoxib is combined with Feprazone.
Robenacoxib The risk or severity of adverse effects can be increased when Robenacoxib is combined with Feprazone.
Aminophenazone The risk or severity of adverse effects can be increased when Aminophenazone is combined with Feprazone.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Feprazone.
SC-236 The risk or severity of adverse effects can be increased when Feprazone is combined with SC-236.
NS-398 The risk or severity of adverse effects can be increased when Feprazone is combined with NS-398.
Firocoxib The risk or severity of adverse effects can be increased when Firocoxib is combined with Feprazone.
Morniflumate The risk or severity of adverse effects can be increased when Morniflumate is combined with Feprazone.
Talniflumate The risk or severity of adverse effects can be increased when Talniflumate is combined with Feprazone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul